Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Ferumoxytol Enhanced Magnetic Resonance Angiography for Cardiovascular Assessment in Late-stage Chronic Kidney Disease

NCT02997046 is registered in ClinicalTrials.gov with Sokratis Stoumpos as lead sponsor.

NCT NCT02997046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02997046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Ferumoxytol Enhanced Magnetic Resonance Angiography for Cardiovascular Assessment in Late-stage Chronic Kidney Disease
Lead sponsor
Sokratis Stoumpos
Phase
Observational
Overall status
Completed
Start date
December 12, 2016
Completion date
September 1, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula, ferric compounds, kidney transplantation, magnetic resonance angiography, vascular grafting